AB
ITOS

Amalgamated Bank’s iTeos Therapeutics ITOS Stock Holding History

Amalgamated Bank’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-825
Closed -$8K – 3012
2025
Q2 		$8K Hold
825
– – ﹤0.01% 2529
2025
Q1 		$5K Hold
825
– – ﹤0.01% 2661
2024
Q4 		$6K Hold
825
– – ﹤0.01% 2663
2024
Q3 		$8K Hold
825
– – ﹤0.01% 2553
2024
Q2 		$12K Hold
825
– – ﹤0.01% 2348
2024
Q1 		$11K Sell
825
-1,375
-63% -$15K ﹤0.01% 2391
2023
Q4 		$24K Sell
2,200
-8,374
-79% -$83K ﹤0.01% 2568
2023
Q3 		$116K Buy
10,574
+1,357
+15% +$17.4K ﹤0.01% 1949
2023
Q2 		$122K Sell
9,217
-952
-9% -$13.6K ﹤0.01% 1993
2023
Q1 		$138K Sell
10,169
-791
-7% -$14.2K ﹤0.01% 1931
2022
Q4 		$214K Hold
10,960
– – ﹤0.01% 1840
2022
Q3 		$209K Buy
10,960
+1,304
+14% +$30K ﹤0.01% 1828
2022
Q2 		$199K Buy
9,656
+703
+8% +$16.7K ﹤0.01% 1875
2022
Q1 		$288K Buy
+8,953
New +$325K ﹤0.01% 1788

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Amalgamated Bank's ITOS Position: Q3 2025 in Review

Amalgamated Bank sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 825 shares — an estimated $8K sold.

Amalgamated Bank first reported a position in ITOS in Q1 2022 and held it in 14 quarters. The position peaked at $288K in Q1 2022. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • Amalgamated Bank reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Amalgamated Bank sold 825 iTeos Therapeutics shares in Q3 2025, an estimated $8K.
  • Amalgamated Bank first reported a position in iTeos Therapeutics in Q1 2022 and held it in 14 quarters.
  • Amalgamated Bank's iTeos Therapeutics position peaked at $288K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Amalgamated Bank's 13F filing for Q3 2025, filed 29 Oct 2025.